Regulatory Affairs Outsourcing Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Regulatory Affairs Outsourcing Market, By Services Type

7.1.  Regulatory Affairs Outsourcing Market, By Services Type, 2020-2030

7.1.1.    Regulatory Consulting

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Legal Representation

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Regulatory Writing & Publishing

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Product Registration & Clinical Trial Applications

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Other Services

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Regulatory Affairs Outsourcing Market, By Size Type

8.1.  Regulatory Affairs Outsourcing Market, By Size Type, 2020-2030

8.1.1.    Small

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Large

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Medium

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Regulatory Affairs Outsourcing Market, By Category Type

9.1.  Regulatory Affairs Outsourcing Market, By Category Type, 2020-2030

9.1.1.    Drugs

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Generics

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Innovators

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Biologics

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Biotech

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    ATMPs

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Medical devices

9.1.7.1.        Market Revenue and Forecast (2016-2030)

9.1.8.    Therapeutic

9.1.8.1.        Market Revenue and Forecast (2016-2030)

9.1.9.    Diagnostic

9.1.9.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Regulatory Affairs Outsourcing Market, By Indication Type

10.1.        Regulatory Affairs Outsourcing Market, By Indication Type, 2020-2030

10.1.1.  Oncology

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Neurology

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Cardiology

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Immunology

10.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Regulatory Affairs Outsourcing Market, By Stage

11.1.        Regulatory Affairs Outsourcing Market, By Stage, 2020-2030

11.1.1.  Preclinical

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Clinical

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  PMA (Post Market Authorization)

11.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Regulatory Affairs Outsourcing Market, By End-use

12.1.        Regulatory Affairs Outsourcing Market, By Size Type, 2020-2030

12.1.1.  Medical Device Companies

12.1.1.1.      Market Revenue and Forecast (2016-2030)

12.1.2.  Pharmaceutical Companies

12.1.2.1.      Market Revenue and Forecast (2016-2030)

12.1.3.  Biotechnology Companies

12.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 13.      Global Regulatory Affairs Outsourcing  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, By Services (2016-2030)

13.1.2.  Market Revenue and Forecast, By Size (2016-2030)

13.1.3.  Market Revenue and Forecast, By Category (2016-2030)

13.1.4.  Market Revenue and Forecast, By Indication (2016-2030)

13.1.5.  Market Revenue and Forecast, By Stage (2016-2030)

13.1.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, By Services (2016-2030)

13.1.7.2.      Market Revenue and Forecast, By Size (2016-2030)

13.1.7.3.      Market Revenue and Forecast, By Category (2016-2030)

13.1.7.4.      Market Revenue and Forecast, By Indication (2016-2030)

13.1.8.  Market Revenue and Forecast, By Stage (2016-2030)

13.1.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.1.9.  Rest of North America

13.1.9.1.      Market Revenue and Forecast, By Services (2016-2030)

13.1.9.2.      Market Revenue and Forecast, By Size (2016-2030)

13.1.9.3.      Market Revenue and Forecast, By Category (2016-2030)

13.1.9.4.      Market Revenue and Forecast, By Indication (2016-2030)

13.1.10.               Market Revenue and Forecast, By Stage (2016-2030)

13.1.11.               Market Revenue and Forecast, By End-use (2016-2030)

13.1.11.1.    

13.2.        Europe

13.2.1.  Market Revenue and Forecast, By Services (2016-2030)

13.2.2.  Market Revenue and Forecast, By Size (2016-2030)

13.2.3.  Market Revenue and Forecast, By Category (2016-2030)

13.2.4.  Market Revenue and Forecast, By Indication (2016-2030)

13.2.5.  Market Revenue and Forecast, By Stage (2016-2030)

13.2.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.2.7.   

13.2.8.  UK

13.2.8.1.      Market Revenue and Forecast, By Services (2016-2030)

13.2.8.2.      Market Revenue and Forecast, By Size (2016-2030)

13.2.8.3.      Market Revenue and Forecast, By Category (2016-2030)

13.2.9.  Market Revenue and Forecast, By Indication (2016-2030)

13.2.10.               Market Revenue and Forecast, By Stage (2016-2030)

13.2.10.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.11.               Germany

13.2.11.1.   Market Revenue and Forecast, By Services (2016-2030)

13.2.11.2.   Market Revenue and Forecast, By Size (2016-2030)

13.2.11.3.   Market Revenue and Forecast, By Category (2016-2030)

13.2.12.               Market Revenue and Forecast, By Indication (2016-2030)

13.2.13.               Market Revenue and Forecast, By Stage (2016-2030)

13.2.14.               Market Revenue and Forecast, By End-use (2016-2030)

13.2.14.1.    

13.2.15.               France

13.2.15.1.   Market Revenue and Forecast, By Services (2016-2030)

13.2.15.2.   Market Revenue and Forecast, By Size (2016-2030)

13.2.15.3.   Market Revenue and Forecast, By Category (2016-2030)

13.2.15.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.2.16.               Market Revenue and Forecast, By Stage (2016-2030)

13.2.16.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.17.               Rest of Europe

13.2.17.1.   Market Revenue and Forecast, By Services (2016-2030)

13.2.17.2.   Market Revenue and Forecast, By Size (2016-2030)

13.2.17.3.   Market Revenue and Forecast, By Category (2016-2030)

13.2.17.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.2.18.               Market Revenue and Forecast, By Stage (2016-2030)

13.2.18.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, By Services (2016-2030)

13.3.2.  Market Revenue and Forecast, By Size (2016-2030)

13.3.3.  Market Revenue and Forecast, By Category (2016-2030)

13.3.4.  Market Revenue and Forecast, By Indication (2016-2030)

13.3.5.  Market Revenue and Forecast, By Stage (2016-2030)

13.3.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, By Services (2016-2030)

13.3.7.2.      Market Revenue and Forecast, By Size (2016-2030)

13.3.7.3.      Market Revenue and Forecast, By Category (2016-2030)

13.3.7.4.      Market Revenue and Forecast, By Indication (2016-2030)

13.3.8.  Market Revenue and Forecast, By Stage (2016-2030)

13.3.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.10.               China

13.3.10.1.   Market Revenue and Forecast, By Services (2016-2030)

13.3.10.2.   Market Revenue and Forecast, By Size (2016-2030)

13.3.10.3.   Market Revenue and Forecast, By Category (2016-2030)

13.3.10.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.3.11.               Market Revenue and Forecast, By Stage (2016-2030)

13.3.11.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.12.               Japan

13.3.12.1.   Market Revenue and Forecast, By Services (2016-2030)

13.3.12.2.   Market Revenue and Forecast, By Size (2016-2030)

13.3.12.3.   Market Revenue and Forecast, By Category (2016-2030)

13.3.12.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.3.12.5.   Market Revenue and Forecast, By Stage (2016-2030)

13.3.12.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.13.               Rest of APAC

13.3.13.1.   Market Revenue and Forecast, By Services (2016-2030)

13.3.13.2.   Market Revenue and Forecast, By Size (2016-2030)

13.3.13.3.   Market Revenue and Forecast, By Category (2016-2030)

13.3.13.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.3.13.5.   Market Revenue and Forecast, By Stage (2016-2030)

13.3.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, By Services (2016-2030)

13.4.2.  Market Revenue and Forecast, By Size (2016-2030)

13.4.3.  Market Revenue and Forecast, By Category (2016-2030)

13.4.4.  Market Revenue and Forecast, By Indication (2016-2030)

13.4.5.  Market Revenue and Forecast, By Stage (2016-2030)

13.4.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, By Services (2016-2030)

13.4.7.2.      Market Revenue and Forecast, By Size (2016-2030)

13.4.7.3.      Market Revenue and Forecast, By Category (2016-2030)

13.4.7.4.      Market Revenue and Forecast, By Indication (2016-2030)

13.4.8.  Market Revenue and Forecast, By Stage (2016-2030)

13.4.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.10.               North Africa

13.4.10.1.   Market Revenue and Forecast, By Services (2016-2030)

13.4.10.2.   Market Revenue and Forecast, By Size (2016-2030)

13.4.10.3.   Market Revenue and Forecast, By Category (2016-2030)

13.4.10.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.4.11.               Market Revenue and Forecast, By Stage (2016-2030)

13.4.12.               Market Revenue and Forecast, By End-use (2016-2030)

13.4.13.               South Africa

13.4.13.1.   Market Revenue and Forecast, By Services (2016-2030)

13.4.13.2.   Market Revenue and Forecast, By Size (2016-2030)

13.4.13.3.   Market Revenue and Forecast, By Category (2016-2030)

13.4.13.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.4.13.5.   Market Revenue and Forecast, By Stage (2016-2030)

13.4.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.14.               Rest of MEA

13.4.14.1.   Market Revenue and Forecast, By Services (2016-2030)

13.4.14.2.   Market Revenue and Forecast, By Size (2016-2030)

13.4.14.3.   Market Revenue and Forecast, By Category (2016-2030)

13.4.14.4.   Market Revenue and Forecast, By Indication (2016-2030)

13.4.14.5.   Market Revenue and Forecast, By Stage (2016-2030)

13.4.14.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, By Services (2016-2030)

13.5.2.  Market Revenue and Forecast, By Size (2016-2030)

13.5.3.  Market Revenue and Forecast, By Category (2016-2030)

13.5.4.  Market Revenue and Forecast, By Indication (2016-2030)

13.5.5.  Market Revenue and Forecast, By Stage (2016-2030)

13.5.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, By Services (2016-2030)

13.5.7.2.      Market Revenue and Forecast, By Size (2016-2030)

13.5.7.3.      Market Revenue and Forecast, By Category (2016-2030)

13.5.7.4.      Market Revenue and Forecast, By Indication (2016-2030)

13.5.8.  Market Revenue and Forecast, By Stage (2016-2030)

13.5.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.5.9.  Rest of LATAM

13.5.9.1.      Market Revenue and Forecast, By Services (2016-2030)

13.5.9.2.      Market Revenue and Forecast, By Size (2016-2030)

13.5.9.3.      Market Revenue and Forecast, By Category (2016-2030)

13.5.9.4.      Market Revenue and Forecast, By Indication (2016-2030)

13.5.9.5.      Market Revenue and Forecast, By Stage (2016-2030)

13.5.9.6.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 14.  Company Profiles

14.1.              Accell Clinical Research, LLC

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              GenPact Ltd

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Criterium, Inc

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              PRA Health Sciences

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              Promedica International

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              WuXi AppTec, Inc

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              Medpace

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Pharmaceutical Product Development, LLC (PPD)

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              Charles River Laboratories International, Inc.

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           ICON plc

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

14.11.           Covance

14.11.1.               Company Overview

14.11.2.               Product Offerings

14.11.3.               Financial Performance

14.11.4.               Recent Initiatives

14.12.           Parexel International Corporation; Inc.

14.12.1.               Company Overview

14.12.2.               Product Offerings

14.12.3.               Financial Performance

14.12.4.               Recent Initiatives

14.13.           Freyr

14.13.1.               Company Overview

14.13.2.               Product Offerings

14.13.3.               Financial Performance

14.13.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

Glossary of Terms